4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001209191-17-007722
$PHIOCIK 0001533040operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:16 PM ET
Size
5.4 KB
Accession
0001209191-17-007722
Insider Transaction Report
Form 4
Kontulis Caitlin
Secretary & Controller
Transactions
- Award
Stock option (right to buy)
2017-02-01+2,500→ 2,500 totalExercise: $0.63Exp: 2027-02-01→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The stock option vests 12.5% on the six month anniversary of the grant date, 12.5% on the one year anniversary of the grant date, and 25% on each of the second, third, and fourth anniversaries of the grant date thereafter.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:16 PM ET
- Size
- 5.4 KB